M S Sever
Overview
Explore the profile of M S Sever including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
382
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vanholder R, Gallego D, Sever M
J Nephrol
. 2022 Mar;
35(2):377-380.
PMID: 35246798
No abstract available.
2.
Khishigsuren B, Demir E, Akgul S, Temurhan S, Ucar A, Dirim A, et al.
Transplant Proc
. 2019 May;
51(4):1115-1117.
PMID: 31101183
Introduction: Seasonal influenza is an important cause of morbidity and mortality in the post-transplant period; therefore, the influenza vaccination has been recommended for all kidney transplant recipients before the influenza...
3.
Temurhan S, Akgul S, Caliskan Y, Artan A, Kekik C, Yazici H, et al.
Transplant Proc
. 2017 Mar;
49(3):541-545.
PMID: 28340830
Background: The serum levels of galactose-deficient immunoglobulin (Ig)A1 (Gd-IgA1) represent the most promising candidate biomarker for IgA nephropathy (IgAN). The aim of this study was to evaluate the serum levels...
4.
Demir E, Yegit O, Erol A, Akgul S, Caliskan B, Bayraktar A, et al.
Transplant Proc
. 2017 Mar;
49(3):477-480.
PMID: 28340816
Introduction: The crossmatch test is essential prior to kidney transplantation (tx) to confirm compatibility between the donor and the recipient. However, its results can be misleading due to "undetectable antibodies"...
5.
Caliskan B, Yazici H, Gulluoglu M, Caliskan Y, Turkmen A, Sever M
Transplant Proc
. 2014 Dec;
47(1):158-60.
PMID: 25480525
Chronic granulomatous disease (CGD) is a genetic disease caused by structural mutations in the enzyme NADPH oxidase that results in severe immunodeficiency. End-stage renal disease occurs in this patient population...
6.
Celtik A, Alpay N, Celik A, Sezer T, Turkmen A, Camsari T, et al.
Transplant Proc
. 2013 Apr;
45(3):904-7.
PMID: 23622583
Background: Renal transplantation is the best renal replacement therapy because it significantly improves patient survival. The developments in transplantation and increasing number of patients with end-stage renal disease (ESRD) have...
7.
Vanholder R, Sever M
Nephrol Dial Transplant
. 2012 Apr;
27(4):1277-81.
PMID: 22467745
No abstract available.
8.
Yazici H, Caliskan Y, Ozturk S, Ozkan O, Turkmen A, Sever M
Transplant Proc
. 2011 Jun;
43(5):1566-9.
PMID: 21693235
Background: Reflux nephropathy (RN) has an important place among the etiologies of end-stage renal disease (ESRD). In this retrospective study we sought to analyze posttransplantation complications among renal transplant recipients...
9.
Vanholder R, Borniche D, Claus S, Correa-Rotter R, Crestani R, Ferir M, et al.
Nephron Clin Pract
. 2010 Sep;
117(3):c184-97.
PMID: 20805691
The response of the nephrological community to the Haiti and Chile earthquakes which occurred in the first months of 2010 is described. In Haiti, renal support was organized by the...
10.
Karahan G, Seyhun Y, Oguz F, Kekik C, Onal E, Caliskan Y, et al.
Transplant Proc
. 2009 Nov;
41(9):3651-4.
PMID: 19917361
Exposure to human leukocyte antigens (HLA) via blood transfusions, pregnancies, and previous transplantations can result in anti-HLA antibody production. The presence of anti-HLA antibodies in recipient sera before transplantation is...